| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 3 | 10 | 810 | $1,040 | $1.7M |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 3 | 20 | 350 | $1,170 | $776.4K |
| 92507 | The provider treats a patient with communication and hearing difficulties by directly interacting with the patient. He assesses the patient with impairment in his ability to make sounds, along with… | 8 | 340 | 2,970 | $80 | $711.1K |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 2 | 210 | 1,470 | $60 | $615K |
| A0429 | Ambulance service, basic life support, emergency transport (bls-emergency) | 3 | 90 | 1,720 | $90 | $577.3K |
| 97530 | The provider uses various activities during direct contact with the patient to improve the patient’s functional performance. Use this code for each 15 minutes of activity. | 7 | 350 | 2,590 | $70 | $550.2K |
| A0427 | Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) | 4 | 90 | 1,720 | $110 | $525.8K |
| 99283 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a low level of medical decision making. | 4 | 340 | 110 | $40 | $450.5K |
| 99284 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making. | 9 | 350 | 100 | $50 | $446.9K |
| 99285 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a high level of medical decision making. | 10 | 200 | 1,680 | $50 | $443.2K |